Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting

Abstract

This study underscores the effectiveness of nirsevimab in preventing medically attended LRTI in infants in outpatient settings and emphasizes the importance of a catch-up immunization program to reduce the disease burden in primary care.